Log in to save to my catalogue

Effects of glycopyrronium bromide versus anisodamine hydrobromide in preventing nausea and vomiting...

Effects of glycopyrronium bromide versus anisodamine hydrobromide in preventing nausea and vomiting...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4074b3a060ba44debaf595da5189ccce

Effects of glycopyrronium bromide versus anisodamine hydrobromide in preventing nausea and vomiting and relieving spasm after ERCP: a randomized controlled trial

About this item

Full title

Effects of glycopyrronium bromide versus anisodamine hydrobromide in preventing nausea and vomiting and relieving spasm after ERCP: a randomized controlled trial

Publisher

United States: PeerJ. Ltd

Journal title

PeerJ (San Francisco, CA), 2025-07, Vol.13, p.e19582, Article e19582

Language

English

Formats

Publication information

Publisher

United States: PeerJ. Ltd

More information

Scope and Contents

Contents

Postoperative nausea and vomiting (PONV) frequently occur in patients undergoing endoscopic retrograde cholangiopancreatography (ERCP) under general anesthesia. Glycopyrronium bromide, an anticholinergic medication, is believed to not only relieve gastrointestinal spasms but also effectively prevent PONV.
To compare the incidence of nausea and v...

Alternative Titles

Full title

Effects of glycopyrronium bromide versus anisodamine hydrobromide in preventing nausea and vomiting and relieving spasm after ERCP: a randomized controlled trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4074b3a060ba44debaf595da5189ccce

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4074b3a060ba44debaf595da5189ccce

Other Identifiers

ISSN

2167-8359

E-ISSN

2167-8359

DOI

10.7717/peerj.19582

How to access this item